ArticleAntimicrobial agents and chemotherapy2015

A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infections.

Christopher P Locher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.